Genelux (GNLX) Company Overview

Profile

Full Name:

Genelux Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 26, 2023

Indexes:

Not included

Description:

Genelux Corporation (GNLX) is a biotechnology company focused on developing innovative cancer therapies. They use a unique approach involving oncolytic viruses, which selectively target and destroy cancer cells while sparing healthy tissue. Their goal is to improve treatment options and outcomes for cancer patients.

Key Details

Price

$4.47

Annual Revenue

$170.00 K(-98.46% YoY)

Annual EPS

-$1.16(-425.12% YoY)

Annual ROE

-145.31%

Beta

1.60

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 15, 24 HC Wainwright & Co.
Buy
Oct 29, 24 Guggenheim
Buy
Aug 27, 24 Roth MKM
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jun 3, 24 Benchmark
Speculative Buy
May 31, 24 Benchmark
Speculative Buy
May 13, 24 HC Wainwright & Co.
Buy
Apr 3, 24 Benchmark
Speculative Buy
Apr 2, 24 HC Wainwright & Co.
Buy
Nov 27, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Genelux?
  • Does Genelux pay dividends?
  • What sector is Genelux in?
  • What industry is Genelux in?
  • What country is Genelux based in?
  • When did Genelux go public?
  • Is Genelux in the S&P 500?
  • Is Genelux in the NASDAQ 100?
  • Is Genelux in the Dow Jones?
  • When was Genelux's last earnings report?
  • When does Genelux report earnings?
  • Should I buy Genelux stock now?

What is the ticker symbol for Genelux?

The ticker symbol for Genelux is NASDAQ:GNLX

Does Genelux pay dividends?

No, Genelux does not pay dividends

What sector is Genelux in?

Genelux is in the Healthcare sector

What industry is Genelux in?

Genelux is in the Biotechnology industry

What country is Genelux based in?

Genelux is headquartered in United States

When did Genelux go public?

Genelux's initial public offering (IPO) was on January 26, 2023

Is Genelux in the S&P 500?

No, Genelux is not included in the S&P 500 index

Is Genelux in the NASDAQ 100?

No, Genelux is not included in the NASDAQ 100 index

Is Genelux in the Dow Jones?

No, Genelux is not included in the Dow Jones index

When was Genelux's last earnings report?

Genelux's most recent earnings report was on Nov 14, 2024

When does Genelux report earnings?

The next expected earnings date for Genelux is Apr 1, 2025

Should I buy Genelux stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions